Impact of platinum-based chemotherapy on the prognosis of early triple-negative breast cancer: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Impact of platinum-based chemotherapy on the prognosis of early triple-negative breast cancer: a systematic review and meta-analysis

Published:2022-11-24 Issue: Volume: Page:
ISSN:1591-9528
Container-title:Clinical and Experimental Medicine
language:en
Short-container-title:Clin Exp Med

Author:

Zhao Fuxing,Shen Guoshuang,Dong Qiuxia,Xin Yuanfang,Huo Xingfa,Wang Miaozhou,Liu Zhen,Zhao Yi,Ren Dengfeng,Xie Qiqi,Liu Zhilin,Li Zitao,Gao Lihong,Du Feng,Zhao Jiuda

Funder

This work was supported by grants from the Thousand Talents of Program of Highend Innovation of Qinghai Province in China

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10238-022-00940-y.pdf

Reference44 articles.

1. Dass SA, Tan KL, Selva Rajan R, Mokhtar NF, Mohd Adzmi ER, Wan Abdul Rahman WF, Tengku Din TADA, Balakrishnan V. Triple negative breast cancer: a review of present and future diagnostic modalities. Med (Kaunas). 2021;57(1):62. https://doi.org/10.3390/medicina57010062.

2. Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363:1938–48. https://doi.org/10.1007/s10354-010-0773-6.

3. Sharma P, Klemp JR, Kimler BF, et al. Germline BRCA mutation evaluation in a prospective triple-negative breast cancer registry: implications for hereditary breast and/or ovarian cancer syndrome testing. Breast Cancer Res Treat. 2014;145(3):707–14.

4. Lips EH, Mulder L, Oonk A, et al. Triple-negative breast cancer: BRCAness and concordance of clinical features with BRCA1-mutation carriers. Br J Cancer. 2013;108:2172–7. https://doi.org/10.1038/bjc.2013.144.

5. Kelland L. The resurgence of platinum-based cancer chemotherapy. Nat Rev Cancer. 2007;7(8):573–84. https://doi.org/10.1038/nrc2167.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-Targeted Oxaliplatin(IV) Prodrug Delivery Based on ROS-Regulated Cancer-Selective Glycan Labeling;Journal of Medicinal Chemistry;2024-05-13

2. Research Progress on New Adjuvant Treatment Strategies and Molecular Typing of Triple-Negative Breast Cancer;Advances in Clinical Medicine;2024